R. Andrew Eckert

This is a page dedicated to get more information for investors to evaluate the management style of R. Andrew Eckert who is a Chief Exec. Officer of Eclipsys Corp.

Here on this page we are inviting all readers to discuss R. Andrew Eckert. You may anonymously post comments with any information that they have about R. Andrew Eckert. You can post comments about their management style or whatever you want to talk about concerning their ability as an executive. Please refrain from personal attacks.

Here is a copy of personal Bio that we found:

R. Andrew Eckert joined Eclipsys Corporation in October 2005 and became President and Chief Executive Officer and joined the Board of Directors on November 14, 2005. From March 2004 to October 2005, Mr. Eckert was CEO of SumTotal Systems, Inc., a provider of learning and business performance technologies and services. From 2002 to March 2004, he was CEO of Docent, Inc., until it merged with Click2learn to form SumTotal Systems. Previously, Mr. Eckert spent 11 years with ADAC Laboratories, , a publicly traded provider of healthcare enterprise radiology and cardiology information systems and integrated imaging solutions, where he served as CEO (1997 to 2001), Chairman (1999 until its sale to Philips Medical Systems in December 2000), and President (1994 to 1997). Prior to ADAC, he worked in the consulting and finance industries with Goldman Sachs, Summit Partners and Marakon Associates. Mr. Eckert serves on the Boards of Directors of Connetics Corporation, a specialty pharmaceuticals company, and Varian Medical Systems, Inc., a manufacturer of integrated cancer therapy systems. He is a Fellow of the College of Nuclear Medicine and co-chairman of the Pacific Vascular Research Foundation, a vascular disease research and public awareness organization.